Article
Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients
25 Feb 2015
Abstract excerpt
Telomere dysfunction and fusion can drive genomic instability and clonal evolution in human tumours, including breast cancer. Telomere length is a critical determinant of telomere function and has been evaluated as a prognostic marker in several tumour types, but it has yet to be used in the clinical setting. Here we show that high-resolution telomere length analysis, together with a specific telomere fusion...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
